Health In Tech announced the voluntary extension of the lock-up period for its executive management team, vice presidents, and Board of Directors.
The extension adds six months to the original twelve-month lock-up period established during the Company's IPO.
All shares held by current executives and the Board of Directors will remain restricted from sale or transfer until June 20, 2026.
Leadership Commitment
The leadership team's decision to extend the lock-up period demonstrates their confidence in the company's long-term growth and initiatives.
Financial Results
Health In Tech raised $9.2 million in its IPO and has been investing in system enhancements, network expansion, and service offerings.
- The voluntary extension of the lock-up period signals strong confidence in Health In Tech's future prospects and strategic direction.
- By limiting the sale or transfer of shares, the company aims to align the interests of executives with long-term shareholder value.
Health In Tech's commitment to extending the lock-up period reflects a strategic move to showcase stability and confidence in its growth trajectory and market initiatives.